UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Find out which S&P 500 ETF has the lowest expense ratio and how it affects retirement investing. This intro covers why costs matter for long-term gains and what to compare when choosing an ETF.
27,916 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
As Alphabet shifts its advertising footprint and data strategy, Disney investors just really need to understand the p...
Vinod Khosla stepped in after Elon Musk pulled back from OpenAI’s pledge, funding a high-stakes bet that transformed ...
MicroStrategy stock rose about 5% as Bitcoin momentum boosted interest in its sizable BTC treasury, underscoring the ...
Treasury Secretary Scott Bessent declares the United States will not intervene in oil futures despite Iran tensions, ...
Regulators push a major redefinition of crypto assets, moving away from SEC enforcement and toward a framework that l...
Hybrids now make up about 20% of U.S. vehicle sales in Q4 2025, signaling a major shift in consumer buying and the tr...
Disney faces a growing disney narrative problem wall as Wall Street questions leadership, strategy, and long-term pro...
A small group of stocks power long-term wealth, while the majority underperform. This report explains how to find the...
Bitcoin holds near a critical level as CME's volatility futures near launch, stoking bets on a push toward the mid-80...
As AI chips grab headlines, investors wonder if will cerebras soar after its IPO. While history offers clues, the pat...
Elon Musk’s xAI sent a rare media email about a Memphis turbine permit, signaling a public-facing shift and the retur...